Sarai Palanca

Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor

Bárbara Hämmerle, Yania Yáñez, Sarai Palanca et al. · PLoS ONE · 2013 · 71 citations · Full text

Medicine, Oncology, Pharmacology +15

Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients

Óscar Fuster, Marta Llop, Sandra Dolz et al. · Leukemia Research · 2013 · 46 citations

Medicine, Molecular Biology, Oncology +17

High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations

Inmaculada de Juan, Eva Esteban, Sarai Palanca et al. · Breast Cancer Research and Treatment · 2008 · 43 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers

Edurne Arriola, Reyes Bernabé, Rosario García Campelo et al. · JCO Precision Oncology · 2023 · 43 citations · Full text

Medicine, Oncology, Pharmacoeconomics +16

TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients

Yania Yáñez, David Hervás, Elena Grau et al. · Journal of Cancer Research and Clinical Oncology · 2015 · 39 citations · Full text

Medicine, Cancer Biology, Oncology +13